Literature DB >> 12187928

Amelioration of relapsing polychondritis in a child treated with oral collagen.

M J Navarro1, G C Higgins, K M Lohr, L K Myers.   

Abstract

Relapsing polychondritis (RP) is a disease characterized by inflammation and the destruction of cartilage. The detection of antibodies to native type II collagen (CII) in the sera of some patients with relapsing polychondritis suggests that autoimmunity to this cartilage specific protein plays a role in the pathogenesis of the disease. RP is so rare that controlled therapeutic trials have not been carried out. We describe herein a child with RP who had amelioration of symptoms and a deviation in the cellular immune response to CII after being treated with daily oral CII as a toleragen.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12187928     DOI: 10.1097/00000441-200208000-00009

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  4 in total

Review 1.  Emerging opportunities for site-specific molecular and cellular interventions in autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2010-01-27       Impact factor: 3.199

Review 2.  Relapsing polychondritis in childhood: three case reports, comparison with adulthood disease and literature review.

Authors:  Adriana R Fonseca; Sheila K F de Oliveira; Marta C F Rodrigues; Ierecê L Aymoré; Romeu C Domingues; Flavio R Sztajnbok
Journal:  Rheumatol Int       Date:  2012-01-01       Impact factor: 2.631

3.  Critical airway involvement in relapsing polychondritis.

Authors:  Camilla Gorard; Saleheen Kadri
Journal:  BMJ Case Rep       Date:  2014-09-11

Review 4.  Clinical analysis of 15 patients with relapsing auricular polychondritis.

Authors:  Huang Yang; Li Peng; Mei Jian; Li Qin
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-03-17       Impact factor: 2.503

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.